12th Global Pharmacovigilance & clinical trials summit

From Verify.Wiki
Jump to: navigation, search
12th Global Pharmacovigilance & clinical trials summit
Date 2018-07-17
Place Sydney, Australia

12th Global Pharmacovigilance & Clinical Trials Summit

"The 12th Global Pharmacovigilance & Clinical Trail Summit is scheduled on July 16-17, 2018 in Sydney, Australia. This conferences is a platform for attendees to network and participate in discussions about drug development trials and Pharmacovigilance."

This is a 2 day event with presentations by and exhibition opportunities for vendors to showcase novel technologies.

Attendees who would benefit from this conference include students, scientists, researchers and industry. [1]

We take great opportunity to bring to your kind notice that we are launching Global Pharmacovigilance 2018, with valuable suggestions and feedback of Global Pharmacovigilance 2017, and we would be delighted to invite you to attend at the upcoming "12th Global Pharmacovigilance & Clinical Trials Summit" during July 09-10, 2018 Sydney, Australia with the theme "Comprehend Multiple Facets of Pharmacovigilance and Clinical Trials." Conference Highlights includes:Pre-clinical Research & Clinical TrialsAdverse Drug ReactionPharmacovigilance and Risk Management Good. Pharmacovigilance PracticeDrug SafetyClinical Trials on Various DisordersClinical Data Management and AnalysisCase Report Forms in Clinical TrialsClinical Pharmacology and BiopharmaceuticsChallenges in Pharmacy PracticeRegulatory AffairsClinical Research and StatisticsPV for biologics and biosimilarsCurrent & Future Scenario of Pharmacovigilance

Submit your abstract at : http://globalpharmacovigilance.pharmaceuticalconferences.com/abstract-submission.php For more queries email us at globalpharmacovigilance@conferenceseries.netYou should enter description content for your listing.


Start Date:
Monday, 9 July, 2018
End Date:
Tuesday, 10 July, 2018 5:00pm
  • Biologics versus biosimilars: Are they similar molecules? Do they share similar drug safety profile?
  • The latest trends of IQ and brain size and effects of lifestyle and environmental

Factors on cranial capacity        

  • Consideration of antimicrobial resistance in Campylobacter spp. in cynomolgus monkeys from Asian countries
  • Title: Challenges for sustenance
  • How to do data mining in pharmacovigilance
  • Adverse drug reaction reporting by patients in 50 countries
  • The effectiveness of antibiotic-loaded bone cement for preventing postoperative infection in patients undergoing total knee arthroplasty
  • Preparation and tumour-suppressing effects of folic acid-targeted, temperature-sensitive magnetoliposomes in ovarian cancer
  • Patient safety culture in Hamad Medical Corporation (HMC), Doha, Qatar       
  • Challenges in breast cancer treatment and drug safety
  • From visiting a physician to expecting antibiotics: Korean perspectives and practices toward respiratory tract infections
  • New developments in adverse drug reaction of ART and tertiary care        
  • Open access pharmacovigilance databases: Analysis of 11 databases

Who should attend

Pharmacovigilance Students,

Pharmacovigilance Researchers,Scientists & Teachers

Medical Colleges,

Pharmaceutical Industries,

Pharmacovigilance Associations and Societies,

Pharmacovigilance Training Institutes,

Software Developing Companies,

Medical Devices Manufacturing Companies,

Data Management Companies,

Business Entrepreneurs,

Also, Directors/Senior Directors/Executive Directors and Vice Presidents/Senior Vice Presidents/Executive Vice Presidents and Heads/Leaders/Partners of:

CROs and CMOs Clinical Research Sites Pharma/Biotech and Medical Device industries Hospitals, Associations University Faculties scientists who are related to clinical and medical research like:


Senior Professors,

Assistant Professors,

Associate Professor,

Research Scholars,

Ph.D Students,


Track 1: Drug Safety

Drug safety is associated with adverse effects of pharmacological agents including side effects, product quality, and medication error in drug usage, inefficacy, and fake drugs. Patient Safety, Drug Interaction (drug-drug and food-drug interaction) Drug Pharmacokinetic, and Adverse Drug Reaction are several terms involved with Drug Safety. Companies have to conduct audits to ensure drug safety to ensure their compliance with international standards of laws, regulations, and guidance.

This track focuses on Drug Safety Updates, Drug Safety Solutions, Training, Surveillance, Services & Software, Reporting & Monitoring.

Track 2: Adverse Drug Reactions

The aim is to minimize adverse drug reactions to improve drug safety through evaluating and reporting adverse events. PK-PD studies are also used to enhance patient safety. Pharmacodynamics is the study of the molecular, biochemical, and physiological effects of drugs on cellular systems and site of action. Pharmacokinetics focuses on how the body affects the drug, in ADME terms. Today, Clinical Pharmacology techniques and pharmacologists use different techniques to explain and manipulate the pharmacological action for safer use health concerns.

This track provides information for drug product manufacturers, professionals, and consumers to report and informative B2B meetings can be planned.

Track 3: Clinical Research and Statistics

Track 4: Pre-Clinical and Clinical Trials

Track 5: Clinical Trials on Various Disorders

Track 6: Case Reports in Clinical Trials

Track 7: Good Pharmacovigilance Practice

Track 8: Pharmacovigilance Significance & Scope

Track 9: Pharmacovigilance and Risk Management

Track 10: Clinical Data Base Management

Data management plays an important role in the process of drug development and allowing early access to patients. A standardized approach is needed from Phase 1 to post-marketing trials.

Track 11: Analysis of Data quality and Management

Track 12: PV Consulting And Business opportunity

Track 13: Biopharmaceutics

Track 14: Regulatory Affairs

Regulatory Affairs is involved in all the stages of drug development and post-marketing activities. Clinical trials must adhere to regulatory guidelines.

Track 15: Pharmacy Practices and its Challenges

Track 16: Entrepreneurs Investment Meet


Oncology, Dermatology, Nephrology, Neurology, Gastroenterology, Hepatology, Cardiology, Infectious Disease

Organizer Details

Conference organized by conference series LLC

Neurology is the study of injuries, disorders, diagnosis and treatment of thebrain, spine and nervoussystem including their coverings, blood vessels, and all effector tissues. There More than 600 known neurological disorders are there which affects our nervous system severely but still for most of the diseases treatment options are very limited and research is going on.

JW Marriott Dubai


  1. https://globalpharmacovigilance.pharmaceuticalconferences.com/

Verification history